Pulse Biosciences, Inc. PLSE Proceeds From Warrant Exercises
Proceeds From Warrant Exercises at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s proceeds from warrant exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s proceeds from warrant exercises?
- Pulse Biosciences, Inc. (PLSE) reported proceeds from warrant exercises of $130K in Q1 2026.
- How has Pulse Biosciences, Inc.'s proceeds from warrant exercises changed year-over-year?
- Pulse Biosciences, Inc.'s proceeds from warrant exercises decreased by 99.1% year-over-year, from $14.08M to $130K.
- What is the long-term trend for Pulse Biosciences, Inc.'s proceeds from warrant exercises?
- Over 2 years (2022 to 2025), Pulse Biosciences, Inc.'s proceeds from warrant exercises has grown at a 2229.7% compound annual growth rate (CAGR), from $26K to $14.11M.
- What does proceeds from warrant exercises mean?
- This metric represents the cash inflows received by the company from the exercise of outstanding warrants by holders. It reflects the capital raised through the conversion of derivative instruments into common equity, providing insight into the company's ability to generate liquidity from existing financial commitments.